When considering PEGylation for a protein drug, how do you decide what PEGylation chemistry to use?

When considering PEGylation for a protein drug, how do you decide what PEGylation chemistry to use?

For protein PEGylation, there are two main options, the type of conjugate chemical and the PEG structure. The choice of chemical agent will determine the attachment site on the protein and whether PEGylation is random or site-specific. For example, amine-reactive PEGs are commonly used because the protein naturally contains available amine groups in its structure and the amine is often available on the surface. In addition, the reaction conditions of amine chemicals were mild. Amine PEGylation typically results in multiple PEG molecules per protein. However, the amine PEGylation is also nonspecific, leading to random conjugation of positional isomers and the emergence of heterogeneous product groups. An N-terminal amine PEGylation strategy can be employed to improve site selectivity by exploiting the lower pKa of the N-terminal amine in the protein and using pegylated chemicals that act at lower reaction pH. Due to the limited availability of individual cysteine residues in the protein, sulfhydryl group-based conjugation is more optional. In addition, site-specific PEGylation can also be used in bioorthogonal reaction chemical agents. Both sulfhydryl and site-specific PEGylation often require genetic engineering and modification of the protein to incorporate free sulfhydryl groups or non-native functional groups. In addition to conjugation chemistry, the choice of PEG size and geometry is critical. Large PEG molecules are not readily removed by glomerular filtration and may cause tissue vacuolization. Branched PEG can provide better shielding and improve circulation time. Having a variety of conjugated chemical formulations and structures PEG is essential to find the best drug choice for you.

Aladdin offers a variety of functionalized PEG options that can be adapted to a variety of conjugation strategies.